Safer radiation for chest tumors with wearable heart monitoring
Part of Cancer, Heart & circulation, Injuries & trauma clinical trials.
This trial is testing whether a lower radiation dose and a wearable heart monitor can reduce the risk of heart rhythm problems in people receiving chest radiation for cancer. It may help those at moderate-to-high risk of heart side effects from treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor in the chest area that needs radiation therapy.
- You are getting radiation with the goal of curing your cancer.
- Your doctor expects you to live more than 4 months.
- You are 20 years or older.
- You are in good enough health to do daily activities (ECOG score 0-2).
- Your risk of heart problems from radiation is considered moderate or high (not low).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that monitors heart health during cancer treatment. It uses a simple on-body sensor alongside your regular echocardiogram to see if it can detect heart changes early.
This study tests whether a wearable heart monitor can help detect heart problems early in people receiving cancer treatment. It may help doctors manage heart health during therapy.
This trial tests whether common heart medicines (statins or ACE-inhibitors) can protect the heart during cancer radiation therapy. It is for adults who are about to start chest radiation and have not taken these drugs before.
This trial uses a special scoring system (ML Score) to predict if you might develop heart problems while receiving anthracycline chemotherapy or HER2-targeted therapies. It helps doctors decide on the best heart monitoring plan before starting treatment.
This trial asks people getting radiation therapy for lung cancer to use a wearable device and smartphone app to track their activity and symptoms. The goal is to learn how this treatment affects patients day-to-day.
This study looks at how chest radiation affects heart function and the immune system, and whether it is safe in people with lung, esophageal, breast, or thymus cancer who have not had chest radiation before.
Hear when a new Cardiotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.